| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.91B | 50.62B | 48.62B | 43.77B | 34.52B | 26.48B |
| Gross Profit | 10.26B | 10.02B | 10.41B | 8.83B | 9.08B | 8.10B |
| EBITDA | 1.86B | 1.42B | 2.95B | 934.87M | 2.37B | 3.50B |
| Net Income | -355.72M | -435.33M | 1.00B | -1.55B | 431.07M | 2.14B |
Balance Sheet | ||||||
| Total Assets | 34.65B | 37.58B | 36.09B | 36.90B | 31.78B | 28.97B |
| Cash, Cash Equivalents and Short-Term Investments | 4.76B | 3.44B | 3.19B | 3.68B | 4.15B | 8.28B |
| Total Debt | 15.80B | 16.59B | 15.68B | 16.30B | 14.31B | 13.56B |
| Total Liabilities | 25.36B | 27.30B | 26.28B | 28.19B | 22.05B | 19.64B |
| Stockholders Equity | 9.29B | 10.27B | 9.80B | 8.70B | 9.74B | 9.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 535.81M | 748.94M | -1.98B | 278.94M | 1.18B |
| Operating Cash Flow | 0.00 | 849.97M | 1.37B | -1.27B | 1.03B | 1.65B |
| Investing Cash Flow | 0.00 | -955.47M | -835.12M | -864.45M | -4.59B | -2.33B |
| Financing Cash Flow | 0.00 | 141.48M | -1.50B | 1.52B | -789.07M | 4.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥15.46T | 36.98 | 12.80% | 0.78% | 7.09% | 7.51% | |
78 Outperform | ¥337.23B | 20.82 | ― | 2.04% | -0.69% | -29.88% | |
77 Outperform | ¥71.48B | 5.81 | ― | 1.49% | 18.20% | 28.13% | |
70 Outperform | ¥111.08B | 12.85 | ― | 3.02% | -14.47% | -26.11% | |
64 Neutral | ¥13.25B | -1,824.58 | 1.21% | 0.97% | 2.36% | -72.81% | |
62 Neutral | ¥521.79B | 41.82 | 6.61% | 2.35% | -9.06% | -35.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |